Heart failure and arrhythmias together pose a critical healthcare issue with high risks of morbidity and mortality globally. Emerging evidence underscores the significance of the arrhythmia burden as a prognostic factor in patients suffering from both atrial fibrillation and heart failure. Pioneering trials like the CASTLE-HTx trial have notably demonstrated that a combination of catheter ablation and guideline-directed medical therapy substantially reduces the risk of death, the need for left ventricular assist devices, or urgent heart transplantation compared to medical therapy alone. In addition to catheter ablation's proven benefits in controlling severe ventricular arrhythmias, pacemaker interventions for bradyarrhythmias in heart failure patients remain a crucial consideration, often requiring evaluations about the simultaneous implementation of ICD and/or CRT based on individual patient profiles.
This Research Topic aims to explore comprehensive management strategies and outcomes in heart failure patients afflicted with arrhythmias. Specifically, the focus will be on the efficacy of early intervention through medication or catheter ablation in atrial arrhythmias, and the potential benefits of early or preemptive catheter ablation in ventricular arrhythmias due to ischemic or non-ischemic cardiomyopathy. Another key objective is to assess the patient-centered outcomes of various device therapies such as pacemakers, ICDs, and CRTs in this population.
To gather further insights into the complex interplay between arrhythmia and heart failure, we welcome articles addressing, but not limited to, the following themes:
- Early rhythm control strategies in atrial arrhythmias among heart failure patients.
- Innovative approaches to managing ventricular arrhythmias in heart failure, including ischemic and non-ischemic cardiomyopathies.
- The role of device therapy in managing both arrhythmia and heart failure, focusing on pacemakers, ICDs, and CRTs.
- Exploration of neuromodulation techniques in treating heart failure and arrhythmias.
- The challenges and outcomes of managing arrhythmias post heart transplantation or ventricular assist device implantation.
Heart failure and arrhythmias together pose a critical healthcare issue with high risks of morbidity and mortality globally. Emerging evidence underscores the significance of the arrhythmia burden as a prognostic factor in patients suffering from both atrial fibrillation and heart failure. Pioneering trials like the CASTLE-HTx trial have notably demonstrated that a combination of catheter ablation and guideline-directed medical therapy substantially reduces the risk of death, the need for left ventricular assist devices, or urgent heart transplantation compared to medical therapy alone. In addition to catheter ablation's proven benefits in controlling severe ventricular arrhythmias, pacemaker interventions for bradyarrhythmias in heart failure patients remain a crucial consideration, often requiring evaluations about the simultaneous implementation of ICD and/or CRT based on individual patient profiles.
This Research Topic aims to explore comprehensive management strategies and outcomes in heart failure patients afflicted with arrhythmias. Specifically, the focus will be on the efficacy of early intervention through medication or catheter ablation in atrial arrhythmias, and the potential benefits of early or preemptive catheter ablation in ventricular arrhythmias due to ischemic or non-ischemic cardiomyopathy. Another key objective is to assess the patient-centered outcomes of various device therapies such as pacemakers, ICDs, and CRTs in this population.
To gather further insights into the complex interplay between arrhythmia and heart failure, we welcome articles addressing, but not limited to, the following themes:
- Early rhythm control strategies in atrial arrhythmias among heart failure patients.
- Innovative approaches to managing ventricular arrhythmias in heart failure, including ischemic and non-ischemic cardiomyopathies.
- The role of device therapy in managing both arrhythmia and heart failure, focusing on pacemakers, ICDs, and CRTs.
- Exploration of neuromodulation techniques in treating heart failure and arrhythmias.
- The challenges and outcomes of managing arrhythmias post heart transplantation or ventricular assist device implantation.